OPTN 0.93 (-8.82%)
US68404V1008Drug ManufacturersDrug Manufacturers - Specialty & Generic

OptiNose (OPTN) Competitor Comparison

We are evaluating the key criteria listed to compare OptiNose (OPTN) against its competitors in the Drug Manufacturers - Specialty & Generic industry.

Earnings per Share - OPTN ranking 24 / 55

These are the competitors of OptiNose in the industry Drug Manufacturers - Specialty & Generic ranked by earnings per share
1. Zoetis ZTS
5.08
2. Amphastar Pharmaceuticals AMPH
2.57
3. SCYNEXIS SCYX
1.39
4. Collegium Pharmaceutical COLL
1.27
5. Taro Pharmaceutical Industries TARO
1.22
6. Embecta EMBC
0.96
7. Pacira BioSciences PCRX
0.87
8. ANI Pharmaceuticals ANIP
0.84
9. Eagle Pharmaceuticals EGRX
0.82
10. Procaps Group PROC
0.51
11. Vifor Pharma G2AB.F
0.46
12. Phibro Animal Health PAHC
0.37
13. Kolinpharma KIP.MI
0.21
14. Kamada KMDA
0.15
15. Green Thumb Industries R9U2.F
0.14
16. PetIQ PETQ
0.07
17. Organogenesis Holdings ORGO
0.04
18. Supernus Pharmaceuticals SUPN
0.02
19. Perrigo PRGO
-0.03
20. Societal CDMO SCTL
-0.14
21. Cronos Group CRON
-0.18
22. Journey Medical DERM
-0.21
23. Ascend Wellness Holdings AAWH
-0.23
24. OptiNose OPTN
-0.31
25. Curaleaf Holdings CURLF
-0.32
26. Tilray Brands TLRY
-0.42
27. Cumberland Pharmaceuticals CPIX
-0.43
28. Regencell Bioscience Holdings RGC
-0.45
29. Amneal Pharmaceuticals AMRX
-0.47
30. Teva Pharmaceutical Industries TEVA
-0.48
31. Jupiter Wellness JUPW
-0.59
32. Harrow Health HROW
-0.75
33. Alimera Sciences ALIM
-0.77
34. Zynerba Pharmaceuticals ZYNE
-0.85
35. Theratechnologies THTX
-0.91
36. ProPhase Labs PRPH
-0.98
37. Ayr Wellness 3KJB.F
-1.07
38. Evolus EOLS
-1.08
39. Alpha Teknova TKNO
-1.16
40. Bausch Health Companies BHC
-1.62
41. Universe Pharmaceuticals UPC
-1.7
42. Avadel Pharmaceuticals AVDL
-2
43. Elanco Animal Health ELAN
-2.43
44. Alvotech ALVO
-2.51
45. Relmada Therapeutics RLMD
-3.28
46. Solid Biosciences SLDB
-4.83
47. Linc LNC
-4.92
48. Ironwood Pharmaceuticals IRWD
-6.33
49. Flora Growth FLGC
-6.34
50. Catalent CTLT
-7.1
51. Clever Leaves Holdings CLVR
-11.39
52. Neoleukin Therapeutics NLTX
-12.28
53. Biofrontera BFRI
-13.61
54. Emergent BioSolutions EBS
-14.85
55. MedAvail Holdings MDVL
-35.56

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.